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Pseudomonas aeruginosa is a priority pathogen for the development of new antibiotics, particularly because
multi-drug-resistant strains of this bacterium cause serious nosocomial infections and are the leading cause of
death in cystic fibrosis patients. Pyocins, bacteriocins of P. aeruginosa, are potent and diverse protein
antibiotics that are deployed during bacterial competition. Pyocins are produced by more than 90% of P.
aeruginosa strains and may have utility as last resort antibiotics against this bacterium. In this study, we
explore the antimicrobial activity of a newly discovered pyocin called pyocin G (PyoG). We demonstrate that
PyoG has broad killing activity against a collection of clinical P. aeruginosa isolates and is active in a Galleria
mellonella infection model. We go on to identify cell envelope proteins that are necessary for the import of
PyoG and its killing activity. PyoG recognizes bacterial cells by binding to Hur, an outer-membrane TonB-
dependent transporter. Both pyocin and Hur interact with TonB1, which in complex with ExbB–ExbD links the
proton motive force generated across the inner membrane with energy-dependent pyocin translocation
across the outer membrane. Inner-membrane translocation of PyoG is dependent on the conserved inner-
membrane AAA+ ATPase/protease, FtsH. We also report a functional exploration of the PyoG receptor. We
demonstrate that Hur can bind to hemin in vitro and that this interaction is blocked by PyoG, confirming the role
of Hur in hemin acquisition.
© 2020 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).Introduction
Antibiotic-resistant Pseudomonas aeruginosa is a
common cause of lung and wound infections in
immunocompromised patients. The World Health
Organisation lists this organism as a pathogen of
critical priority for the development of new antibiotics
[1]. Pyocins are protein antibiotics with narrow-
spectrum activity that could be developed into new
antimicrobials for treating P. aeruginosa infections,
as demonstrated in various in vivo models [2].
Pyocins belong to a larger group of proteinaceous
molecules called bacteriocins, which are used byuthors. Published by Elsevier Ltd. This
ses/by/4.0/).bacteria to compete for resources by killing compet-
itors, usually of the same bacterial species. Pyocins
are multi-domain proteins produced in combination
with an immunity protein. The immunity protein binds
to the cytotoxic domain at the pyocin C terminus to
inhibit its activity and protect the producing strain
from the lethal effects of the pyocin. Once released
by producing strains, the N-terminal sequences of
pyocins interact with proteins in the cell envelope in
order to assemble energized import machineries
called translocons [3]. Multiple protein–protein inter-
actions are required for pyocin import, which
explains their narrow-spectrum killing activity andis an open access article under the CC BY license (http://
Journal of Molecular Biology (2020) 432, 3869–3880
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locons are assembled aids in their development as
species-specific antimicrobials [2].
Different pyocins target different cell envelope
components in order to kill P. aeruginosa. Nuclease
pyocins translocate to the cytoplasm to degrade
nucleic acids. To do so, they first bind an outer-
membrane receptor, which can be common polysac-
charide antigen [4] or an outer-membrane protein [5,6].
They next have to exploit an outer-membrane protein
translocator, usually by hijacking a nutrient importer.
The energy source for translocation is the proton
motive force (PMF) across the inner membrane. In
general, the PMF and translocation are linked through
the TonB–ExbD–ExbB system in P. aeruginosa [7].
Finally, nuclease pyocins likely also require an inner-
membrane translocator to enter the cell, but no such
import route has been identified in this organism.
Pyocins show high strain specificity by targeting
particular receptors and translocators in the outer
membrane [8]. Some pyocins share homology at the
N terminus, which implies they use the same
receptor to deliver different cytotoxic domains into
the cell [9]. Pyocins sharing the same receptor are
treated as members of the same pyocin group.
Strain coverage of a pyocin depends on how
widespread its receptor is in P. aeruginosa ge-
nomes. Therefore, an important requirement for the
potential use of pyocins in the clinic is to pair up
different pyocin groups with their receptors. If these
pairs are known, it can also be predicted from
genomic data which strains of P. aeruginosa are
likely to be sensitive to which pyocins.
A limitation in the future biomedical use of pyocins
is the occurrence of pyocin resistance mechanisms.
P. aeruginosa is intrinsically resistant to all pyocins it
produces, since it will also have immunity protein
genes for them. Additionally, resistance can occur
through spontaneous mutations affecting proteins
required for pyocin translocation. These problems
can, however, be overcome through the use of
cocktails comprising toxins that have different cell
envelope targets and different immunity proteins.
Mining P. aeruginosa genomes for novel pyocin
genes is therefore an important step in developing
this class of antibiotics as therapeutics. We have
developed a bioinformatics pipeline for searching
genomes of different bacteria for nuclease bacterio-
cins, which represents a valuable tool for exploring
the diversity of pyocins [9]. The pipeline led to the
discovery of several new putative pyocin genes,
including pyocin G (PyoG). PyoG has an N-terminal
region homologous to previously described pyocins
from the S1 group (S1, S13 or SD1 and S6) and a
cytotoxic domain homologous to carocin D, an
endonuclease bacteriocin from Pectobacterium car-
otovorum [10]. In this study, we expressed and
purified this newly identified pyocin, and demon-
strated its cytotoxic activity against clinical isolates ofP. aeruginosa and its efficacy in aGalleria mallonella
infection model. We also determined the cell
envelope components necessary for translocation
of the pyocin, showing that pyocins from the S1
group share a common receptor, Hur (hemin uptake
receptor). We further show that Hur has a role in
hemin acquisition and hence may have a role in P.
aeruginosa virulence.Results and Discussion
PyoG is a novel pyocin from the S1 group
PyoG is a 640-amino-acid toxin that belongs to the
S1 group in which the first 483 residues are similar to
pyocins S1, S6 and S13 (Figure S1). This suggests
that all S1-group pyocins share the same cell entry
route since pyocin translocation domains are generally
located at the N terminus [5,6,11]. However, this entry
mechanism is currently unknown. We first functionally
annotated the domains of PyoG by sequence homol-
ogywith other bacteriocins.Sanoet al. havepreviously
determined two functional domains in the conserved
N-terminal region of pyocin S1 (Figure S2, domains I
and II) and linked them to receptor binding and cell
import albeit that the proteins involved were not
identified [12]. Residues 1–483 are predicted to be
helical, which is the case for the translocation domains
of other pyocins for which structures have been
reported [5,6]. The cytotoxic domain, and its corre-
sponding immunity protein, is not homologous to any
other pyocin but to carocin D (Figure S1). Carocin D is
a nuclease bacteriocin from P. carotovorum that
shows DNase activity in vitro [10], implying PyoG is
also a nuclease. This is supported by the presence of
the Pyocin S domain (Figure S2), a conserved domain
shared among all nuclease bacteriocins, yet missing
from pyocins, which attack the cell envelope [9]. The
function of this domain has yet to be determined, but is
thought to be linked to the inner-membrane transloca-
tion step in gram-negative bacteria.
We heterologously expressed PyoG in complex
with its immunity protein ImG and assessed its
activity (Figure S3). Purified PyoG killed P. aerugi-
nosa PAO1 with a nanomolar MIC (Figure S3B). To
assess P. aeruginosa strain coverage, we tested the
activity of PyoG against a collection of 32 P.
aeruginosa clinical isolates. One of the factors that
influences bacteriocin strain coverage is immunity.
Strains that produce a pyocin have the correspond-
ing immunity gene in the same operon, but immunity
protein genes can also be orphans. If the PyoG
immunity is not being produced by many P.
aeruginosa strains, then it would be anticipated to
have a good strain coverage. PyoG immunity is
present in 11 of 6973 strains in the PubMLST
Database [13]. This is a small number of strains
3871Targeted Killing of Pseudomonas aeruginosawhen compared to the pyocin S1 immunity, which is
present in 744 strains. Indeed, 90% of screened
strains were sensitive to PyoG, where most had
nanomolar MICs (Figure 1(a)). Good strain coverage
also indicates that the PyoG translocation machinery
is common in P. aeruginosa genomes.
We also tested the efficacy of PyoG against P.
aeruginosa strains using a G. mallonella infection
model.G. mallonella was exposed to a lethal dose of
P. aeruginosa PAO1. Three-hour post-infection
larvae were treated with PyoG, which led to rescue
of larvae (Figure 1(b)). In conclusion, PyoG is a
newly discovered pyocin from the S1 group, which
shows good strain coverage and in vivo activity
against P. aeruginosa infection.
Defining the translocation machinery for PyoG
We first investigated if any of the cell envelope
proteins employed by other nuclease bacteriocinsFigure 1. PyoG is active against clinical isolates of P. aerug
aeruginosa PAO1. (a) PyoG MICs for a collection of P. aerugino
MICs values are represented as shades of blue. Most strains ar
a lethal dose of P. aeruginosa PAO1 in the G. mallonella infec
lacks the receptor for the pyocin.are also necessary for PyoG import. One such
conserved protein is the inner-membrane AAA+
ATPase/protease FtsH. FtsH is required for inner-
membrane translocation and proteolytic processing
of the nuclease domains of several colicins that kill
Escherichia coli cells [14]. It is not known if FtsH is
important for nuclease pyocin toxicity in P. aerugi-
nosa. We therefore tested PyoG killing activity
against an ftsH deletion mutant of P. aeruginosa
PAO1. The mutant was resistant to PyoG and
sensitivity could be restored by complementation
from plasmid-expressed ftsH (Figure 2(a)). Previous
studies have shown that the protease and ATPase
activities of FtsH are both required for colicin activity
[14] and that proteolytic processing of colicin D and
E3 nuclease domains during import depends on
FtsH [15]. It is therefore likely that nuclease pyocins
similarly require an FtsH-dependent cleavage step
during inner-membrane transport, but this remains to
be experimentally demonstrated.inosa and can rescue G. mallonella from a lethal dose of P.
sa clinical isolates. Resistant strains are shown in red, and
e sensitive to the pyocin. (b) In vivo activity of PyoG against
tion model. PAO1 Δhur is a PyoG-resistant mutant which
Figure 2. Plate and liquid killing assays with 10 μM PyoG reveal which cell envelope proteins are involved in its import.
For OD600, mean of three biological replicates with standard deviations is shown. (a) FtsH, an inner-membrane AAA+
ATPase/protease, is necessary for PyoG killing activity. P. aeruginosa PAO1 ΔftsH is resistant to PyoG and is unaffected
by the introduction of the empty shuttle vector pMMB190 (ΔftsH pMMB190). However, transformation of PAO1 ΔftsH with
pftsH complemented the ftsH deletion and restored sensitivity to PyoG. (b) TonB1, a protein that links the PMF generated
on the inner membrane with translocation across the outer membrane, is necessary for PyoG killing activity. ΔtonB1
mutant of P. aeruginosa is resistant to PyoG, while ΔtonB2 and ΔtonB3 mutants are sensitive. (c) The killing activity of
PyoG depends on an outer-membrane transporter, Hur. Deletion of hur induces resistance to the pyocin. Sensitivity can be
restored if hur is complemented from a plasmid. Phur is hur cloned from PAO1 into pMMB190. (d) E. coli BL21 (DE3) is not
sensitive to PyoG. PyoG sensitivity in this organism can be induced if transformed with both pTonBB1 and pHur. pTonBB1
is E. coli TonB1–102 translationally fused to P. aeruginosa TonB1201–342 and cloned into pACYCDuet-1 [6]. pHur is hur with
the E. coli OmpF signal sequence, codon optimized for expression in E. coli and cloned into pET21d.
3872 Targeted Killing of Pseudomonas aeruginosaAn inner-membrane protein system that is also
known to be involved in pyocin import is the Ton
system [11]. It is composed of TonB, ExbB, and
ExbD and it transduces the PMF to nutrient
transporters in the outer membrane. P. aeruginosaPAO1 has three TonB proteins: TonB1 (PA5531),
TonB2 (PA0197) and TonB3 (PA0406). TonB1 and
TonB2 have roles in iron acquisition and signaling
[7], while TonB3 is involved in twitching motility and
assembly of extracellular pili [16]. We screened
3873Targeted Killing of Pseudomonas aeruginosatransposon mutants for all three genes and found
that the TonB1 mutant was resistant to PyoG (Figure
2(b)). To confirm TonB1's role in PyoG import, we
purified the periplasmic domain of TonB1 to test its
binding to PyoG. We could demonstrate that TonB1
and PyoG interact in vitro via a pull-down assay
(Figure 3(a)). Therefore, PyoG depends on TonB1
for its energized import into cells.
The identification of TonB1 as a requirement for
PyoG import provided the starting point for finding its
outer-membrane receptor/translocator. The extend-
ed periplasmic region of TonB1 binds to outer-
membrane receptors, which are usually linked to iron
acquisition [7]. Such receptors are called TonB-
dependent transporters (TBDTs) [17]. These are all
β-barrels that share a conserved plug domain (Pfam
domain PF07715) that occludes the β-barrel and a
TonB binding box. Since other pyocins hijack TBDTsFigure 3. Pull-downs of PyoG translocon components. Prot
nickel beads, which were then washed of unbound protein. E
protein marker is shown in the first lane on each gel. Eluate o
protein is shown in the third lane and it verifies that the prey doe
prey is shown in the fourth lane. Positions of proteins with their m
PyoG and the periplasmic region of TonB1 interact in vitro. (b)
of the pyocin. (c) The first 255 residues of PyoG, which are con
to the periplasmic region of TonB1, confirming that this is a To[5], we assumed that this was also the case of PyoG.
By searching the P. aeruginosa PAO1 genome for
TonB plug domains, we found 35 candidate recep-
tors/translocators for PyoG (Supplementary Table
1). We next screened a library of transposon mutants
for all 35 receptors and found that a transposon
insertion into locus PA1302 yielded resistance to
PyoG (Figure 2(c)). Sensitivity to PyoG was restored
if the mutation was complemented from a plasmid,
suggesting this locus codes for the PyoG receptor
and/or translocator.
PA1302 has previously been linked with the import
of pyocin PaeM4 in P. aeruginosa [18] and with
hemin uptake [19]. Therefore, we named the
receptor Hur (Hemin uptake receptor), which we
elaborate below. To test if TonB1 and Hur are
functionally linked to PyoG import, we transformed
these components of the translocon into E. coli usingeins were mixed at equimolar concentrations and bound to
luate content was analyzed on 12% SDS-PAGE gels. A
f the bait protein is in the second lane. Eluate of the prey
s not bind to beads on its own. Eluate for the mix of bait and
olecular masses are labeled on the right side of the gel. (a)
PyoG binds to Hur, confirming its involvement in the import
served among S1-group pyocins, bind to Hur. (d) Hur binds
nB1-dependent transporter.
3874 Targeted Killing of Pseudomonas aeruginosathe strategy developed by Behrens et al. [6]. We
found that E. coli was sensitive to PyoG when co-
transformed with Hur and a chimera of E. coli TonB
and periplasmic P. aeruginosa TonB1 (Figure 2(d)).
This indicates that Hur and periplasmic TonB1 are P.
aeruginosa-specific components of the outer-mem-
brane translocation machinery, with FtsH being
involved in inner-membrane translocation.
Several pyocins have been shown previously to
bind exopolysaccharides such as common polysac-
charide antigen, which concentrates the toxin on the
cell surface, but then require an outer-membrane
protein transporter for translocation [4,6]. Such
pyocins can still bind to the cell surface if the protein
translocator is deleted, but this binding does not lead
to pyocin import [6]. In contrast, some bacteriocins
exploit one or two outer-membrane proteins for
surface recognition and translocation to the peri-
plasm [20,21]. We therefore investigated if Hur is
essential for PyoG to bind to P. aeruginosa cells. WeFigure 4. Hur is required for PyoG to target P. aeruginosa
complemented with Hur expressed from a plasmid (Δhur phur).
was used for labeling. This construct labels the wt strain, but the
hur is complemented from a plasmid. Representative microgr
intensities for 100 cells in the presence and absence of fluoresc
deviations is shown.constructed a PyoG construct for fluorescent label-
ing of live P. aeruginosa PAO1 cells. This construct
lacks the cytotoxic domain of the pyocin and has a
cysteine at the C terminus for conjugation with Alexa
Fluor dyes. This construct labeled PAO1 cells but
could not label the Δhur mutant. Additionally,
complementation with Hur expressed from a plasmid
restored the same fluorescence levels as PAO1
(Figure 4). Moreover, the labeled PyoG is trans-
ported across the outer membrane, since it is
protected from trypsin degradation (Figure S4). The
data demonstrate that Hur is an essential outer-
membrane component for PyoG to bind to the
surface of P. aeruginosa cells, and be imported
into the cell. Finally, PyoG sensitivity of E. coli
expressing Hur and the TonBB1 chimera (Figure 2
(d)) also implies that Hur is the only outer-membrane
component to which PyoG binds and that it likely
plays the role of both receptor and translocator for
PyoG import.cells. (a) Fluorescent labeling of PAO1 wt, Δhur and Δhur
PyoG1–483, conjugated to AF488 via a C-terminal cysteine,
re is loss of labeling if hur is deleted. Labeling is restored if
aphs for each strain are shown. (b) Average fluorescence
ent PyoG. Mean of three biological replicates with standard
3875Targeted Killing of Pseudomonas aeruginosaPyoG and hemin compete for Hur binding
Hur is a TBDT homologous to PhuR, a hemin
transporter in P. aeruginosa [22], HasR, a hemin
transporter in Serratia marcescens [23], and HxuC, a
hemopexin transporter of Haemophilus influenzae
[24]. Even though sequence homology of Hur and
other TBDTs strongly supports its involvement in
hemin acquisition, binding of Hur to this ligand has
not been demonstrated. To find interaction partners
for Hur and shed more light on its function, we
purified the receptor to test its binding to PyoG and
hemin in vitro. Codon optimized hur from P.
aeruginosa PAO1 was cloned with the OmpF signal
sequence (MKRNILAVIVPALLVAGTANA), followed
by an N-terminal His10 tag and a TEV cleavage site
for heterologous expression in E. coli BL21ABCF.
After expression, Hur was purified from E. coli outer
membranes (for details, seeMaterials and Methods).
Since the His tag of Hur could be removed by the
TEV protease, we could use Hur both as bait and as
prey protein in pull-downs on nickel beads. This
enabled us to test if PyoG and hemin both bind to
Hur in vitro, and if PyoG could outcompete hemin for
Hur binding.
We found that full length PyoG binds Hur in vitro
(Figure 3(b)) providing further evidence of this
TBDT's role. Since the N-terminal domains are
conserved among S1 group pyocins and have
been hypothesized to be responsible for receptor
binding [12], we decided to purify the first 255
residues of PyoG and assess its ability to bind Hur.
Interestingly, we found that PyoG1–255 binds Hur
(Figure 3(c)) confirming the role of this conserved
region in receptor binding. Therefore, all S1-group
pyocins probably share Hur as their receptor. We
could not test if the entire conserved region (1–483)
of PyoG binds to Hur since PyoG1–483 was not
soluble in detergent (in which Hur is solubilized).
Finally, to confirm that Hur is a TBDT and interacts
directly with TonB1, we again used the pull-down
assay and we showed that Hur binds periplasmic
TonB1 (Figure 3(d)).
Otero-Asman et al. have shown previously that a
triple PAO1 mutant lacking Hur and two other hemin
uptake receptors (PhuR and HasR) has impaired
growth if hemin is the sole source of iron. We found
that the killing activity of PyoG is supressed in the
presence of iron or hemin (Figure S5), consistent
with the findings of Otero-Asman et al. that Hur
expression is hemin dependent. These experiments
indicate that Hur has a role in hemin uptake.
Therefore, we deployed a spectrophotometric pull-
down assay [25] to assess if purified His-tagged Hur
binds hemin in vitro. Hur was exposed to a molar
excess of hemin and then bound to nickel beads.
After washing off unbound hemin, Hur was eluted
and its UV–Vis spectrum recorded to assess if there
was an increase at 410 nm, corresponding to thehemin peak. The ratio between the hemin and the
280-nm protein peak increased if Hur was exposed
to excess hemin (Figure 5), confirming that Hur binds
hemin. Because previous authors [18,19] named this
receptor HxuA or HxuC (Hemopexin uptake recep-
tor), we also tested via pull-downs if human haem
containing plasma proteins could bind to the
receptor. Hur could not bind to human hemopexin,
hemoglobin A0 or transferrin (Figure S6). Therefore,
we have renamed this protein Hur (Hemin uptake
receptor), as it is more indicative of its role.
We next determined if hemin and PyoG compete
for Hur binding. To test this hypothesis, we per-
formed Hur-hemin pull-downs in the presence of
PyoG lacking a purification tag. We found that PyoG
depleted the amount of hemin bound to Hur in the
pull-down (Figure 5). In this experiment, Hur was first
exposed to hemin and then to the pyocin. PyoG can
therefore displace Hur-bound hemin. These results
have relevance for the clinical application of PyoG.
Hur expression is upregulated under iron starvation if
hemin is the sole source of iron [19]. These are the
conditions that P. aeruginosa encounters in the host,
where iron is bound to plasma proteins or as part of
haem. Therefore, Hur is also upregulated in the host,
as seen from expression profiles of P. aeruginosa
isolated from human respiratory epithelia [26]. This
suggests that PyoG could be active in mammalian
hosts although this has yet to be demonstrated.
Model of PyoG import mechanism into P.
aeruginosa
PyoG, a novel protein antibiotic of P. aeruginosa,
exploits several cell envelope proteins in order to be
imported to the cytoplasm. In this study, we identified
several proteins that comprise the PyoG translocon
(Figure 6). We also elaborated the link between its
receptor, Hur, and hemin, the endogenous
substrate.
PyoG recognizes P. aeruginosa by binding Hur.
Hur is a TonB1-dependent transporter that has a role
in hemin uptake. Binding of the pyocin and hemin to
the receptor is competitive. Currently, evidence
suggests that Hur is not only the receptor but also
the PyoG translocator. Import of the pyocin into the
periplasm depends on TonB1, which is a part of the
ExbB–ExbD complex. This protein system links the
proton-motive force generated across the inner
membrane and the energy-dependent stages of
PyoG translocation across the outer membrane.
Both the receptor and the pyocin bind to TonB1 in
vitro. Therefore, we propose that upon binding of
PyoG to Hur, TonB1 dislodges the plug domain of
the receptor to release the pore of the barrel, and
then also pulls the pyocin into the periplasm, similar
to the import mechanism of pyocin S2 through the
FpvAI receptor [5]. Translocation of the pyocin
through the inner membrane depends on the
Figure 5. Hur binds hemin, a source of iron for P. aeruginosa in mammalian hosts. Hemin binding to Hur can be blocked
by PyoG. (a) Pull-down of hemin with 10 μM His-tagged Hur, in the presence and absence of 10 μM PyoG lacking a
purification tag. Proteins were mixed with a 100× molar excess of hemin and bound to nickel beads. Beads were then
washed of unbound protein and hemin. Absorbance spectra of eluate were measured to detect changes in the 410-nm
hemin peak (enlarged in the upper corner). Representative absorbance spectra are shown. The 410-nm peak is increased
if Hur is exposed to excess hemin, and no hemin peak can be observed if Hur was mixed with PyoG. No considerable 410-
nm peak in the protein free control, containing hemin only, confirms that unbound hemin was washed off the beads and
makes no contribution to the 410-nm absorbance in the eluate. (b) Ratio between the hemin 410-nm peak and the protein
280-nm peak in the eluate indicates that Hur binds hemin in vitro, which is blocked in the presence of PyoG. Mean of three
technical repeats with standard deviations is shown.
3876 Targeted Killing of Pseudomonas aeruginosaAAA+ ATPase/protease FtsH. The pyocin could be
going through the membrane channel of FtsH, which
would likely requires a cleavage step during trans-
location, as observed for E. coli colicins.Materials and Methods
Sequence analysis and genome searches
The bioinformatics pipeline used in the discovery of
PyoG is described by Sharp et al. [9]. All bacteriocin
sequences used in this study are deposited in the
National Center for Biotechnology database under the
following accession numbers: PyoG (GenBank acces-
sion no. ETV05907.1), pyocin S1 (UniProtKB/Swiss-
Prot accession no. Q06583.2), pyocin S6 (GenBankaccession no. KYO98147.1), pyocin S13 (National
Center for BiotechnologyReferenceSequence acces-
sion no. WP_023116694.1), and carocin D (GenBank
accession no. ADH95192.1).
Sequence alignments were made by Clustal
Omega [27] and visualized by ESPript 3.0 [28].
PFAM domains were searched for by SMART [29],
and secondary structure predictions were generated
by PSIPRED [30]. TonB-dependent receptors in the
P. aeruginosa PAO1 genome were identified by
HMMER 3.3 [31] using the TonB plug domain (PFAM
domain PF07715).
Strains and plasmid construction
Genes were amplified by PCR from genomic DNA
or synthesized by Genewiz with codon optimization
for expression in E. coli. All plasmids (Supplementary
3877Targeted Killing of Pseudomonas aeruginosaTable 2)were constructed by restriction enzymedigest
and ligation and propagated in E. coli NEB5α.
All strains (Supplementary Table 1) were cultured
in LB (10 g/L tryptone, 10 g/L NaCl, 5 g/L yeast
extract (pH 7.2)) or M9 media (8.6 mM NaCl,
18.7 mM NH4Cl, 42.3 mM Na2HPO4, 22.0 mM
KH2PO4, 0.4% w/v glucose, 2 mM MgSO4, 0.1 mM
CaCl2) at 37 °C with shaking (140 rpm). E. coli
BL21ΔABCF was cultured in LB Lennox (10 g/L
tryptone, 5 g/L NaCl, 5 g/L yeast extract (pH 7.2)) at
30 °C with shaking (140 rpm). BL21ΔABCF was a
gift from Jack Leo (Addgene plasmid #102270). P.
aeruginosa ΔftsH was grown on LB media without
addition of salt. TonB mutants of P. aeruginosa were
grown in LB media supplemented with 100 μM
FeCl3. All P. aeruginosa transposon mutants were
grown in the presence of 10 μg/ml tetracycline.
Mutants of P. aeruginosa were complemented by
transformation with a shuttle vector pMMB190 in
which a gene of interest was cloned. Transformation
was performed by conjugation with E. coli S17-1.
Equal volumes of P. aeruginosa and S17-1 overnight
cultures were mixed and incubated on top of LB agar
plates for 8 h at 37 °C. Transformants of P.Figure 6. Model of PyoG translocation into P. aeruginosa
membrane translocator. Binding of the pyocin to the receptor is
receptor, PyoG also binds to TonB1, which links the PMF at the
The import process, as with nuclease colicins, requires the innaeruginosa were then selected on 100 μg/ml carbe-
nicilline and 10 μg/ml tetracycline.
Protein expression, purification and quantifica-
tion
All cytoplasmic His-tagged proteins (PyoG in com-
plex with His-tagged immunity protein, PyoG1255,
PyoG1–483, periplasmic domain of TonB1) were
expressed inE. coliBL21(DE3) for 3 h in the presence
of 1 mM IPTG. Cells were pelleted by centrifugation
(4200g, 20 min), resuspended in 50 mM Tris–HCl
(pH 8), 500 mM NaCl, 10 mM imidazole, 1 mM
PMSF) and disrupted by sonication. Cleared lysate
was loaded onto a 5-ml HisTrap FF column and eluted
with a 10- to 250-mM linear gradient of imidazole.
Proteins were further purified by gel filtration chroma-
tography on a HiLoad 26/600 Superdex 200 pg
column equilibrated in 50 mM Tris–HCl (pH 8),
250 mM NaCl. All columns were obtained from GE
Healthcare Life Sciences.
PyoG without a purification tag was prepared by
removing the His-tagged immunity protein by guani-
dine elution, as previously described for colicins [32].. PyoG exploits Hur as both the receptor and the outer-
competitive with that of hemin, its cognate ligand. Like its
inner membrane with translocation at the outer membrane.
er-membrane AAA+ ATPase/protease FtsH.
3878 Targeted Killing of Pseudomonas aeruginosaTen milligrams of the PyoG-ImG complex was bound
to a HisTrap FF column. PyoG was then eluted in
50 mM Tris–HCl (pH 8), 250 mM NaCl, 6 M guani-
dine. Guanidine was removed by dialysis against
50 mM Tris–HCl (pH 8), 250 mM NaCl.
His-tagged Hur, cloned with an E. coli OmpF
signal sequence, was expressed in BL21ΔABCF
cells for 3 h in the presence of 0.1 mM IPTG. Cells
were pelleted by centrifugation (4200g, 20 min) and
disrupted by sonication in 50 mM Tris–HCl (pH 8),
1 mM PMSF. Total membranes were pelleted by
ultracentrifugation at 200,000g for 45 min. Inner-
membrane proteins were removed in 50 mM Tris–
HCl (pH 8), 2% Triton-X 100, and outer membranes
were pelleted by another ultracentrifugation step.
Outer-membrane proteins were extracted in 50 mM
Tris–HCl (pH 8), 2% n-octyl-β-D-GLUCOSIDE (β-OG),
5 mM EDTA. The insoluble fraction was removed by
a final ultracentrifugation step, and EDTA was
removed by a HiPrep 26/10 desalting column. The
outer-membrane extract was then loaded onto a 5-
ml HisTrap FF column equilibrated in 50 mM Tris–
HCl (pH 8), 1% β-OG, 10 mM imidazole. Hur was
eluted using a 10- to 500-mM linear imidazole
gradient and further purified by gel filtration chroma-
tography on a HiLoad 16/600 Superdex 200-pg
column equilibrated in 50 mM Tris–HCl (pH 8), 1%
β-OG. For removing the His tag, 1 mg of TEV
protease was used per 10 mg of protein. TEV and
uncleaved His-tagged Hur were removed using a
HisTrap FF column after a 5-h incubation at room
temperature.
Protein concentrations were measured by con-
verting absorbance at 280 nm with the sequence-
based predicted molar extinction coefficient
(ExPASy ProtParam). Protein masses were con-
firmed by denaturing electrospray ionization mass
spectrometry on proteins diluted in formic acid.Pyocin activity testing
The cytotoxic activity of PyoG was tested by a
plate killing assay. P. aeruginosa was grown at
37 °C in LB media to an OD600 of 0.5. Lawns were
prepared by inoculating 250 μl of culture to 5 ml of
molten soft LB-agar (0.75% agar in LB), which was
poured over LB-agar plates. Three-microliter drops
of PyoG 3-fold serial dilutions, starting at 10 μM,
were spotted onto plates. Cytotoxicity was deter-
mined by observation of clearance zones after
incubation of plates at 37 °C.
Liquid killing assays were performed in 96 flat
bottom plates in a 200-μl volume. LB was used as
growth medium, which was supplemented with
100 μM FeCl3 in case of tonB mutants, or freed of
salt in case of the ftsH mutant. Overnight cultures of
tested strains were set to OD600 of 1 and diluted 100
times in fresh growth medium with or without 10 μMPyoG. OD600 was monitored on a CLARIOstar Plus
microplate reader (BMG Labtech) on 37 °C for 20 h.
All measurements were performed in triplicate.
Galleria mellonella larvae infection model
G. mellonella larvae were obtained from Livefood
UK.P. aeruginosaPAO1was grown under agitation in
LB broth at 37 °C to an OD600 of 0.6. Cells were then
washed twice in sterile phosphate-buffered saline
(PBS) and diluted to the desired inoculum in PBS.
Inoculums were serially diluted and plated on LB agar
plates just before administration for CFU counting.
Groups of 10 larvae were injected with 10 μl of
bacterial suspension in the hemocoel via the last
right pro-limb or PBS as a negative control. Following
challenge, larvaewereplaced in an incubator at 37 °C.
Larvae were treated 3 h post-infection by injection of
10 μl of pyocin in the hemocoel via the last left pro-
limb. Survival was followed for 48 h; larvae were
considered dead when unresponsive to touch. Exper-
iment was conducted in triplicate.
Pull-down experiments
Protein pull-downs were performed either using
PyoG-ImG-His6 complex or His12-Hur as a bait.
Proteins were mixed to a final concentration of
10 μM in binding buffer (50 mM Tris–HCl (pH 8),
250 mM NaCl, with the addition of 1% β-OG if Hur
was used). Three hundred microliters of Ni-NTA
resin (QIAGEN) washed in the same buffer was
added to 100 μl of protein mix. The resin was then
transferred to Spin Columns (Pierce) and washed
until no absorbance at 280 nm could be detected in
the wash. Proteins were eluted in 100 μl of the
binding buffer with the addition of 500 mM imidazole
and run on a 12% SDS-PAGE gel.
Pull-downs with His-tagged Hur as bait were used to
detect hemin binding. Hur (10 μM) was mixed with
1 mM hemin (Sigma) in a 250-μl reaction volume, in
the presence or absence of 10 μMPyoG lacking a His
tag. Ni-NTA resin (750 μl) in binding buffer was added
to the mix and washed on a Spin Column until no
absorbance could be detected at 280 and 410 nm,
where 410 nm is the absorbance maximum for hemin
in binding buffer with β-OG. Proteins were then eluted
in 250 μl of binding buffer with 500 mMi midazole.
Absorbance spectra of eluted proteins and heminwere
measured using a V-550 UV–Visible Spectrophotom-
eter (Jasco) in the 250- to 700-nm range. The relative
amount of hemin to protein was determined by dividing
the 410-nm hemin peak by the 280-nm protein peak.
Experiment was performed in triplicate.
Microscopy with fluorescently-labeled PyoG
PyoG1–483 with a C-terminal cysteine was cova-
lently modified with Alexa Fluor 488 C5 Maleimide
3879Targeted Killing of Pseudomonas aeruginosadye (Invitrogen). Pyocin of 50 μM was reduced with
10 mM DTT for 1 h at room temperature. DTT was
removed on a HiTrap desalting column and protein
then mixed with a 3-fold molar excess of the dye for
1 h at room temperature. The reaction was
quenched with 10 mM DTT and excess dye
removed using a HiLoad 16/600 Superdex 200-pg
column equilibrated in 50 mM Tris–HCl (pH 8),
250 mM NaCl. Labeling efficiency, determined as
described in the manufacturers protocol (Molecular
Probes Inc., 2006), was typically ~100%.
PyoG1–483-AF488 was then used to label P.
aeruginosa PAO1 wt, Δhur and complemented
Δhur pHur cells. All strains were grown in M9
media until OD600 of 0.5. Five milliliters of cells was
then washed in PBS and labeled with 2 μM PyoG1–
483-AF488 for 30 min at room temperature. For the
trypsin protection assay, after labeling cells were
exposed to 0.1 mg/ml trypsin for 30 min at 37 °C as
previously described [5]. All pelleting steps were
performed at 7000g for 3 min. Unbound dye was
removed by washing in PBS, and cells were then
loaded onto 1% agarose pads and imaged using an
Oxford Nanoimager S microscope. Images were
collected at 100-ms exposure and 20% 488-nm laser
power. For every image, 100 frames were collected
and averaged using the Z Project command in Image
J. Average fluorescence was measured in three
fields of view for a total of 100 cells per condition and
was corrected by subtracting the average back-
ground fluorescence. All experiments were conduct-
ed in triplicate.
Supplementary data to this article can be found
online at https://doi.org/10.1016/j.jmb.2020.04.020.Acknowledgments
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